CDMO Samsung Biologics Records 13th Consecutive Month of Revenue Growth in Q1 2023
Contract development and manufacturing organization Samsung Biologics reported revenue of 720.9 billion South Korean won (roughly $538 million) for the first quarter of 2023. The year-over-year increase of 209.6 billion…